Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12123-8. doi: 10.1073/pnas.1201453109. Epub 2012 Jul 10.
We recently demonstrated that differentiation of cytotoxic T cells requires cooperation between T-cell receptor (TCR)/costimulation and γc-cytokines. Here we demonstrate that the transcription factor IFN regulatory factor 8 (IRF8) is expressed in CD8 T cells by the combination of these two signals. More importantly, depletion of IRF8 in these cells abrogated the differentiation of naive CD8 T cells into effector cells in an experimental graft-vs.-host disease mouse model. We also show that IRF8 seems to not operate upstream of other critical factors such as T-bet and eomesodermin, which have been implicated in effector maturation. Collectively, our work shows that IRF8 integrates the TCR/costimulation and γc-cytokine-signaling pathways and mediates the transition of naive CD8 T cells to effector cells, thus identifying IRF8 as one of the molecular regulators of CD8 T-cell differentiation.
我们最近证实,细胞毒性 T 细胞的分化需要 T 细胞受体(TCR)/共刺激和 γc 细胞因子之间的合作。在这里,我们证明转录因子干扰素调节因子 8(IRF8)通过这两种信号的组合在 CD8 T 细胞中表达。更重要的是,在实验性移植物抗宿主病小鼠模型中,耗尽这些细胞中的 IRF8 会阻止幼稚 CD8 T 细胞分化为效应细胞。我们还表明,IRF8 似乎不作用于 T 细胞因子和 Eomesodermin 等其他关键因子的上游,这些因子已被牵连到效应成熟中。总之,我们的工作表明,IRF8 整合了 TCR/共刺激和 γc 细胞因子信号通路,并介导了幼稚 CD8 T 细胞向效应细胞的转化,从而将 IRF8 鉴定为 CD8 T 细胞分化的分子调节剂之一。